AKI Prevention and Early Intervention in Patients Undergoing VAD Placement

Overview

About this study

The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients that will undergo VAD placement.
Patients able to give consent

Exclusion Criteria:

Patients on dialysis (hemodialysis or peritoneal dialysis)
Non-elective VAD placement (VAD implantation decision made within 24 hours)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Qi Qian, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Qi Qian, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials